Justin Bowers
Stock Analyst at Deutsche Bank
(3.56)
# 916
Out of 4,414 analysts
37
Total ratings
46.67%
Success rate
7.34%
Average return
Main Sectors:
17 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher | Maintains: Buy | $600 → $610 | $571.25 | +6.78% | 3 | Apr 25, 2024 | |
| TXG 10x Genomics | Maintains: Buy | $60 → $55 | $26.29 | +109.21% | 2 | Apr 18, 2024 | |
| TECH Bio-Techne | Maintains: Buy | $85 → $82 | $75.60 | +8.47% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Maintains: Hold | $23 → $25 | $24.32 | +2.80% | 3 | Apr 18, 2024 | |
| MEDP Medpace Holdings | Initiates: Hold | $395 | $391.07 | +1.00% | 1 | Mar 18, 2024 | |
| FTRE Fortrea Holdings | Initiates: Hold | $36 | $36.65 | -1.77% | 1 | Mar 6, 2024 | |
| CTLT Catalent | Maintains: Hold | $37 → $45 | $56.34 | -20.13% | 8 | Aug 15, 2023 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Buy | $23 → $17 | $8.80 | +93.18% | 3 | Aug 8, 2023 | |
| ICLR ICON PLC | Maintains: Buy | $280 → $300 | $301.07 | -0.36% | 2 | Jul 14, 2023 | |
| DHR Danaher | Maintains: Buy | $310 → $275 | $246.84 | +11.41% | 2 | Apr 27, 2023 | |
| RGEN Repligen | Initiates: Hold | $180 | $166.31 | +8.23% | 1 | Dec 14, 2022 | |
| WAT Waters | Initiates: Hold | $350 | $315.58 | +10.91% | 1 | Dec 14, 2022 | |
| WST West Pharmaceutical Services | Initiates: Hold | $250 | $368.46 | -32.15% | 1 | Dec 14, 2022 | |
| AMED Amedisys | Maintains: Buy | $175 → $165 | $92.43 | +78.51% | 3 | Oct 24, 2022 | |
| CRL Charles River Laboratories International | Maintains: Buy | $350 → $290 | $229.89 | +26.15% | 1 | Jul 14, 2022 | |
| IQV IQVIA Holdings | Maintains: Buy | $250 → $290 | $222.14 | +30.55% | 1 | Apr 12, 2022 | |
| SEM Select Medical Holdings | Maintains: Buy | n/a | $28.45 | - | 2 | Apr 24, 2020 |
Thermo Fisher
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $571.25
Upside: +6.78%
10x Genomics
Apr 18, 2024
Maintains: Buy
Price Target: $60 → $55
Current: $26.29
Upside: +109.21%
Bio-Techne
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $75.60
Upside: +8.47%
Avantor
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $24.32
Upside: +2.80%
Medpace Holdings
Mar 18, 2024
Initiates: Hold
Price Target: $395
Current: $391.07
Upside: +1.00%
Fortrea Holdings
Mar 6, 2024
Initiates: Hold
Price Target: $36
Current: $36.65
Upside: -1.77%
Catalent
Aug 15, 2023
Maintains: Hold
Price Target: $37 → $45
Current: $56.34
Upside: -20.13%
Maravai LifeSciences Holdings
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $8.80
Upside: +93.18%
ICON PLC
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $301.07
Upside: -0.36%
Danaher
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $246.84
Upside: +11.41%
Repligen
Dec 14, 2022
Initiates: Hold
Price Target: $180
Current: $166.31
Upside: +8.23%
Waters
Dec 14, 2022
Initiates: Hold
Price Target: $350
Current: $315.58
Upside: +10.91%
West Pharmaceutical Services
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $368.46
Upside: -32.15%
Amedisys
Oct 24, 2022
Maintains: Buy
Price Target: $175 → $165
Current: $92.43
Upside: +78.51%
Charles River Laboratories International
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $229.89
Upside: +26.15%
IQVIA Holdings
Apr 12, 2022
Maintains: Buy
Price Target: $250 → $290
Current: $222.14
Upside: +30.55%
Select Medical Holdings
Apr 24, 2020
Maintains: Buy
Price Target: n/a
Current: $28.45
Upside: -